Documents
Highlighted Topics
Most Viewed Questions And Answers
-
Does all research go through the same review process?
No. There are three types of research, each of which receives a different level of review.
- Exempt Research
The University of Washington applies the federal regulations and guidance about exemption to all UW human subjects research, regardless of funding or funding source. The staff of the Human Subjects Division (HSD) are the only individuals authorized to determine that research activity is exempt from federal regulations. In addition to the federal criteria, HSD requires that exempt research involve no more than minimal risk and that interactions with subjects must include some type of consent process that provides the subjects with basic information about the research.
Researchers do not have the authority to determine that their own research qualifies for exempt status. The research may not begin until the researcher has received notification from HSD that the research qualifies for exemption. Exempt status is granted for a five-year period.
- Minimal Risk Research
Research falling into minimal risk categories is reviewed by a subcommittee of the IRB (use form UW 13-11). You may also hear the term "expedited review" used in conjunction with the review of minimal risk research; describing the ability of the research to be reviewed by a subcommittee - not that the review process is necessarily faster.
- More than Minimal Risk Research
Research falling into categories considered to be of more than minimal risk requires review by the full Committee (use form UW 13-11).
- Exempt Research
-
How long does the IRB review process take?
Multiple factors affect the time required for IRB review. They include:
- type of application
- level of review (e.g., exempt, minimal risk, full committee)
- complexity of the study
- involvement of other compliance offices or institutions
- quality and completeness of the application when first submitted
We encourage researchers to plan for sufficient time for review based on the research and their particular situation. Here are some general recommendations based on HSD's current workload:
- Allocate adequate preparation time before submission, in most cases a minimum of two weeks to one month.
- For full IRB review, plan for at least 12 to 16 weeks for the review and approval process.
- For Minimal Risk review, plan for at least 6 to 8 weeks.
- For Exempt review, plan for at least 2 to 3 weeks.
-
What is needed to request a "Waiver of HIPAA Authorization?"
The UW IRB Committees use specific criteria in reviewing requests for a waiver of HIPAA authorization for research. In completing the Human Subjects Review Application (UW 13-11), researchers should explain how:
- The use or disclosure of protected health information involves no more than minimal risk to the privacy, safety, and welfare of the individual;
- The research could not practicably be conducted without the waiver or alteration;
- The research could not practicably be conducted without access to the protected health information;
- There is an adequate plan to protect the identifiers from improper use or disclosure;
- There is an adequate plan to destroy the identifiers at the earliest opportunity consistent with conduct of the research, unless there is a health or research justification for retaining the identifiers or such retention is otherwise required by law; and
- There are adequate written assurances that the protected health information will not be re-used or disclosed to a third party except as required by law, for authorized oversight of the research, or as permitted by an authorization signed by the research subject
In requesting this waiver, researchers should also provide the following information:
- Detailed information about the types of protected health information that will be used, including how it will be used, who will have access to it, and when it will be destroyed;
- What risks are posed by the use of the data, and how they have been minimized
- The justification for access to the data and why they are necessary to conduct the research.
-
What is research?
"Research" means a systematic investigation designed to develop or contribute to generalizable knowledge. Activities that meet this definition constitute "research" for the purposes of the regulations that guide and govern how research is conducted in the United States, whether or not they are supported or funded under a program which is considered research for other purposes. For example, some "demonstration" and "service" programs may include research activities. It may be important to understand the following about research:
- It is basically a study that is done to answer a question.
- Scientists do research because they don't know for sure what works best or to better understand why or how things happen.
- Some other words that describe research are clinical trial, protocol, survey, or experiment.
- Research is not the same as treatment.
-
What should my consent form contain?
Guidance is available regarding consent, including sample forms, on the Consent, Assent and Waivers topic page.
Document Update Schedule
- HSD posts updated documents to the web site on the last Friday of each month. In rare cases, due to an urgent need, an updated document will be posted during the month.
- HSD and the IRB ask that researchers make every effort to use the most recent document version.
- Questions about a specific document version? Contact hsdforms@uw.edu.
- Everything
- Documents
- Keywords
- 0-9 |
- A |
- B |
- C |
- D |
- E |
- F |
- G |
- H |
- I |
- J |
- K |
- L |
- M |
- N |
- O |
- P |
- Q |
- R |
- S |
- T |
- U |
- V |
- W |
- X |
- Y |
- Z
0-9
A
Administrative Closure Policy
Adverse Event Report Form
Appeal of IRB Determination Policy and Procedure
Assent Form for Blood Draw Sample Template: ages 7-12
Assent Form Sample Template: ages 7-12
C
Case Report - IRB and HIPAA Requirements
Case Report Research Self - Determination
CC-IRB - Criteria for Cancer Consortium IRB Review and Transferring Studies from UW IRB to the CC-IRB
CC-IRB - Fred Hutchinson Cancer Research Center Institutional Review Office (IRO)
CC-IRB - The Cancer Consortium
CC-IRB - The FHCRC Protocol Office
CC-IRB - The Seattle Cancer Care Alliance
CC-IRB - UW Confidentiality Agreement
Center, Program, or Training Grant Application
Center, Program, or Training Grant Instructions for Application
Certificate of Confidentiality Cover Sheet
Certificate of Confidentiality Facts
Certificate of Confidentiality Procedure
CITI Web-Based Course in Human Subjects - Registration and Completion
Clinical Trials.gov - Instructions for Responsible Party and Releasing a Study Record
ClinicalTrials.gov - Instructions for Registering Your Trials
ClinicalTrials.gov - Instructions for Updating a Study Record Every 6 Months
ClinicalTrials.gov - Q&A for Registering Studies
ClinicalTrials.gov - Results Registration
ClinicalTrials.gov - Transferring a Study Record from NIH to the UW Investigator
Closure Date of IRB Application
Closure of Human Subjects Research Guidance and Procedure
Compensation for IRB Members
Conditional Approval Policy and Procedure
Conditional Approval Response Form
Confidentiality Agreement
Confidentiality Agreement Guidance
Consent Document Template - HIV Antibody Test
Consent Form Sample Template Non Identifiable De Linked Anonymized Specimens
Consent Form Sample Template: Identifiable Specimens
Consent Form Sample Template: Standard
Consent Sample Template Medical Records Standard
Contract and Consent Form Comparison
D
dbGaP Poster Presentation
Deferral Response Cover
Delayed Onset Human Research
Delayed Onset Human Research Determination Form
Department of Defense - Research Involvement
Department of Defense Addendum to the UW FWA
E
F
Federally Mandated Reporting Policy
Federally Mandated Reporting Procedure
Financial Conflict of Interest
Fred Hutch IRB and UW Compensation Plan Flow Chart
G
Guest Observers at IRB Meetings
Guest Observers at IRB Meetings Guidance
GWAS dbGaP General Guidance
GWAS dbGaP Submission Supplement
H
HIPAA and Research
HIPAA Authorization Template
HIPAA Responsibilities of the IRB and HSD
HSD Metrics: Report 01 (7/1/08 to 12/31/08)
HSD Metrics: Report 02 (10/1/08 to 3/31/09)
HSD Metrics: Report 03 (1/1/09 to 6/30/09)
HSD Metrics: Report 04 (4/1/09 to 9/30/09)
HSD Metrics: Report 05 (7/1/09 to 12/31/09)
HSD Metrics: Report 06 (10/1/09 to 3/31/10)
HSD Metrics: Report 07 (1/1/10 to 6/30/10)
HSD Metrics: Report 08 (4/1/10 to 9/30/10)
HSD Metrics: Report 09 (7/1/10 to 12/31/10)
HSD Metrics: Report 10 (10/1/10 to 3/31/11)
HSD Metrics: Report 11 (1/1/11 to 6/30/11)
HSD Metrics: Report 12 (4/1/11 to 9/30/11)
HSD Metrics: Report 13 (7/1/11 to 12/31/11)
HSD Metrics: Report 14 (10/1/11 to 3/31/12)
HSD Metrics: Report 15 (1/1/12 to 6/30/12)
HSD Metrics: Report 16 (4/1/12 to 9/30/12)
HSD Metrics: Report 17 (7/1/12 to 12/31/12)
HSD Organizational Chart
Human Subject Definition
Human Subjects Review Application Instructions
Human Subjects Review Application: UW 13-11
I
Individual Investigator Agreement
Initial Application: Exempt Status Request
Initial Application: Exempt Status Request-PDF
Instructions to Add or Delete Sections in the Modification Form
IRB Authorization Agreement
IRB Conflict of Interest
IRB Meeting Notes Sheet
IRB Meeting Pledge of Confidentiality
IRB Member and HSD Staff Experience and Expertise
IRB Pocket Guide: Criteria for Approval and Researcher Responsibilities
IRB Pocket Guide: Criteria for IRB Approval & Meeting Operations
J
M
Mail/Delivery Options at the UW Tower
Materials (Consent and Recruitment) Stamped With IRB Approval Procedure
Modification Form
Modification Form Instructions 1 - General
Modification Form Instructions 2 - Information on Sections
N
New DORA Study Numbers and Old HSD Application Numbers
News Item: Increase in Fee
NIH Senior/Key Personnel and Other Significant Contributors
O
Official Posting 1: Stamping Consent/ Revised Mod Form/ Conditional Approval
Official Posting 2: Stamping Consent/ Study Closure/ Revised Forms
Official Posting 3: Revised Confidentiality Agreement
Official Posting 4: American Recovery and Reinvestment Act (ARRA) and IRB Review
Official Posting 5: Paying Research Subjects - Check Request Policy
Official Posting 6: New Policy-Signatures on IRB Forms
Over-enrollment
P
R
Report of Other Problems
Reporting to FDA
Reporting to OHRP
Repository Application
Research Consent
Research Inquiries Guidance for Researchers
Research Non-Compliance: Researcher Overview
Risks of Harm from Standard Care
S
Sample Gatekeeping Form
Screening Query Response Cover
Seattle Biomed Request: Defer Review to Seattle Biomed (Western IRB)
Signatures on IRB Forms
SOP Continuing Review
SOP IRB Actions
SOP Modifications
Sponsor Assurance Letter
Stamped Consent Materials Policy
Status Report - Renewal or Closeout - Form
Subject Payment
Subject Payment Confidentiality and Income Tax
Supplement: Department of Defense (DoD) Involvement
Supplement: Offsite Adverse Event Log
Supplement: Protected and/or Vulnerable Populations
Suspension or Termination of IRB Approval
Swedish IRB Fee Schedule
Swedish IRB Fees Notice
T
Training for Researchers, Research Staff, and Consultants in the Protection of Human Research Subjects (PHRS)
Translation and Interpretation
Transportation for Research Subjects
U
Use of Identifiable Biological Specimens/Data - PDF (formerly Medical Records Review)
Use of Identifiable Biological Specimens/Data - Word (formerly Medical Records Review)
Use of Identifiable Biological Specimens/Data Guidance
Use of Non-Identifiable Biological Specimens/Data Guidance
Use of Non-Identifiable Biological Specimens/Data Review Determination
Use of the UW IRB
Using Records without Consent
UW Compensation Plan Flow Chart for Adverse Events
UW Engagement in VA Research
UW/CC-IRB Cover Sheet
UW/WIRB Clinical Pharmacology Unit (CPU) Consent Template
UW/WIRB Consent Template
UW/WIRB Cover Sheet
UW/WIRB Initial Review Process Diagram
V
W
Waiver Request: Consent or Consent Requirements
Waiver Request: HIPAA Authorization
WebQ Source Document
What to Do and Expect as a Research Subject
What to Do and Expect for Children as Research Subjects
WIRB - Background on WIRB
WIRB - Cancer Consortium Members
WIRB - Conflict of Interest
WIRB - Criteria for Review by WIRB
WIRB - Documentation of Human Subjects Training
WIRB - Final contract between the UW and the sponsor
WIRB - HSD screening before applying to WIRB
WIRB - IRB fees for review
WIRB - Modifications
WIRB - Other regulatory and compliance approvals
WIRB - Partial Waiver of Authorization for Recruitment
WIRB - UW Confidentiality Agreement
WIRB - UW Consent Form
WIRB - UW HIPAA Authorization Form
WIRB - Western IRB's Review Process
WIRB Clinical Pharmacology Unit Fee Schedule
WIRB Clinical Pharmacology Unit Services Brochure
WIRB Fee Schedule 2013

| 